JP7518097B2 - Ｎｔｒｋの発癌性融合を示す候補となる徴候の識別 - Google Patents

Ｎｔｒｋの発癌性融合を示す候補となる徴候の識別 Download PDF

Info

Publication number
JP7518097B2
JP7518097B2 JP2021566992A JP2021566992A JP7518097B2 JP 7518097 B2 JP7518097 B2 JP 7518097B2 JP 2021566992 A JP2021566992 A JP 2021566992A JP 2021566992 A JP2021566992 A JP 2021566992A JP 7518097 B2 JP7518097 B2 JP 7518097B2
Authority
JP
Japan
Prior art keywords
patient
ntrk
patient data
subject
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021566992A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020229152A5 (https=
JP2022531961A (ja
JP2022531961A5 (https=
Inventor
アルント、シュミッツ
エレン、メティン、エルシ
ファイドラ、スタブロプロウ
ミハイル、カチャラ
アンッティ、カールソン
ミッコ、トゥキアイネン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Consumer Care AG
Original Assignee
Bayer Consumer Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Consumer Care AG filed Critical Bayer Consumer Care AG
Publication of JP2022531961A publication Critical patent/JP2022531961A/ja
Publication of JPWO2020229152A5 publication Critical patent/JPWO2020229152A5/ja
Publication of JP2022531961A5 publication Critical patent/JP2022531961A5/ja
Application granted granted Critical
Publication of JP7518097B2 publication Critical patent/JP7518097B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/0464—Convolutional networks [CNN, ConvNet]
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/09—Supervised learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/08—Learning methods
    • G06N3/096—Transfer learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/698—Matching; Classification
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Biophysics (AREA)
  • Computational Linguistics (AREA)
  • Evolutionary Computation (AREA)
  • Computing Systems (AREA)
  • General Engineering & Computer Science (AREA)
  • Mathematical Physics (AREA)
  • Software Systems (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Quality & Reliability (AREA)
  • Multimedia (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021566992A 2019-05-10 2020-04-28 Ｎｔｒｋの発癌性融合を示す候補となる徴候の識別 Active JP7518097B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19173832 2019-05-10
EP19173832.7 2019-05-10
PCT/EP2020/061665 WO2020229152A1 (en) 2019-05-10 2020-04-28 Identification of candidate signs indicative of an ntrk oncogenic fusion

Publications (4)

Publication Number Publication Date
JP2022531961A JP2022531961A (ja) 2022-07-12
JPWO2020229152A5 JPWO2020229152A5 (https=) 2023-01-23
JP2022531961A5 JP2022531961A5 (https=) 2023-01-23
JP7518097B2 true JP7518097B2 (ja) 2024-07-17

Family

ID=66483934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021566992A Active JP7518097B2 (ja) 2019-05-10 2020-04-28 Ｎｔｒｋの発癌性融合を示す候補となる徴候の識別

Country Status (6)

Country Link
US (1) US12217851B2 (https=)
EP (1) EP3966830A1 (https=)
JP (1) JP7518097B2 (https=)
CN (1) CN113785365A (https=)
CA (1) CA3139352A1 (https=)
WO (1) WO2020229152A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4248356A1 (en) 2020-11-20 2023-09-27 Bayer Aktiengesellschaft Representation learning
US11791035B2 (en) * 2021-03-09 2023-10-17 PAIGE.AI, Inc. Systems and methods for artificial intelligence powered molecular workflow verifying slide and block quality for testing
WO2023194090A1 (en) 2022-04-08 2023-10-12 Bayer Aktiengesellschaft Multiple instance learning considering neighborhood aggregations
US20250265832A1 (en) 2022-04-26 2025-08-21 Bayer Aktiengesellschaft Multiple-instance learning based on regional embeddings
WO2023213623A1 (en) 2022-05-03 2023-11-09 Bayer Aktiengesellschaft Dynamic sampling strategy for multiple-instance learning
EP4471710B1 (de) 2023-05-30 2025-12-17 Bayer Aktiengesellschaft Erkennen von artefakten in synthetischen medizinischen aufnahmen
EP4475070B1 (de) 2023-06-05 2026-04-22 Bayer Aktiengesellschaft Erkennen von artefakten in synthetischen medizinischen aufnahmen
EP4492324A1 (de) 2023-07-12 2025-01-15 Bayer AG Erkennen von artefakten in synthetischen medizinischen aufnahmen
US20250045926A1 (en) 2023-07-25 2025-02-06 Bayer Aktiengesellschaft Detection of artifacts in synthetic images
EP4560648A1 (en) 2023-11-22 2025-05-28 Bayer AG Generating synthetic training data
EP4567715A1 (en) 2023-12-06 2025-06-11 Bayer Aktiengesellschaft Generating synthetic representations
WO2025119803A1 (en) 2023-12-06 2025-06-12 Bayer Aktiengesellschaft Generating synthetic medical representations
EP4571650A1 (en) 2023-12-12 2025-06-18 Bayer AG Generating synthetic images
EP4575997A1 (en) 2023-12-18 2025-06-25 Bayer Aktiengesellschaft Generating synthetic images
WO2025190827A1 (en) 2024-03-15 2025-09-18 Bayer Aktiengesellschaft Generation of a synthetic medical image

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050262031A1 (en) 2003-07-21 2005-11-24 Olivier Saidi Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US20080032321A1 (en) 2006-08-07 2008-02-07 General Electric Company System and methods for analyzing images of tissue samples
WO2019084697A1 (en) 2017-11-06 2019-05-09 University Health Network Platform, device and process for annotation and classification of tissue specimens using convolutional neural network

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6754380B1 (en) * 2003-02-14 2004-06-22 The University Of Chicago Method of training massive training artificial neural networks (MTANN) for the detection of abnormalities in medical images
WO2007023522A1 (ja) * 2005-08-22 2007-03-01 National Center Of Neurology And Psychiatry 脳疾患の診断支援方法及び装置
MX349568B (es) * 2010-11-30 2017-08-03 Univ Hong Kong Chinese Deteccion de aberraciones geneticas o moleculares asociadas con el cancer.
CN109478231A (zh) * 2016-04-01 2019-03-15 20/20基因系统股份有限公司 帮助区别良性和恶性放射线照相明显肺结节的方法和组合物
JP6843521B2 (ja) * 2016-04-28 2021-03-17 キヤノン株式会社 画像処理装置及び画像処理方法
US10026173B2 (en) * 2016-11-06 2018-07-17 Dde Mri Solutions Ltd. Diffusion ellipsoid mapping of tissue
US9922421B1 (en) * 2016-11-06 2018-03-20 Hadassa Degani Diffusion ellipsoid mapping of tissue
WO2018156133A1 (en) 2017-02-23 2018-08-30 Google Llc Method and system for assisting pathologist identification of tumor cells in magnified tissue images
US11107189B2 (en) 2017-04-07 2021-08-31 Intel Corporation Methods and systems using improved convolutional neural networks for image processing
US12602772B2 (en) * 2018-01-08 2026-04-14 Progenics Pharmaceuticals, Inc. Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determination
US11164309B2 (en) * 2019-04-10 2021-11-02 International Business Machines Corporation Image analysis and annotation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050262031A1 (en) 2003-07-21 2005-11-24 Olivier Saidi Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US20080032321A1 (en) 2006-08-07 2008-02-07 General Electric Company System and methods for analyzing images of tissue samples
WO2019084697A1 (en) 2017-11-06 2019-05-09 University Health Network Platform, device and process for annotation and classification of tissue specimens using convolutional neural network

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
COUDRAY, Nicolas et al.，Classification and Mutation Prediction from Non-Small Cell Lung Cancer Histopathology Images using Deep Learning，Nat Med.，2018年10月，Vol.24，No.10，p.1559-1567，https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847512/pdf/nihms-1861775.pdf
HECHTMAN, Jaclyn F. et al.，Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions，Am J Surg Pathol，2017年11月，Vol.41，No.11，p.1547-1551，https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636652/pdf/nihms883557.pdf
PENAULT-LLORCA, Frederique et al.，Testing algorithm for identification of patients with TRK fusion cancer，J Clin Pathol，2019年05月09日，Vol.72，p.460-467，https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589488/pdf/jclinpath-2018-205679.pdf

Also Published As

Publication number Publication date
WO2020229152A1 (en) 2020-11-19
CA3139352A1 (en) 2020-11-19
JP2022531961A (ja) 2022-07-12
US20220223261A1 (en) 2022-07-14
CN113785365A (zh) 2021-12-10
EP3966830A1 (en) 2022-03-16
US12217851B2 (en) 2025-02-04

Similar Documents

Publication Publication Date Title
JP7518097B2 (ja) Ｎｔｒｋの発癌性融合を示す候補となる徴候の識別
Schneider et al. Integration of deep learning-based image analysis and genomic data in cancer pathology: A systematic review
US11462325B2 (en) Multimodal machine learning based clinical predictor
Truong et al. Optimization of deep learning methods for visualization of tumor heterogeneity and brain tumor grading through digital pathology
US20250245825A1 (en) Machine-learning-enabled predictive biomarker discovery and patient stratification using standard-of-care data
JP2024534493A (ja) デジタル組織病理画像を使用してがん遺伝型及び処置反応を予測するための機械学習
Al-Ghafer et al. NMF-guided feature selection and genetic algorithm-driven framework for tumor mutational burden classification in bladder cancer using multi-omics data
Huang et al. Performance of a HER2 testing algorithm tailored for urothelial bladder cancer: A Bi-centre study
Feng et al. Ligand-receptor interactions combined with histopathology for improved prognostic modeling in HPV-negative head and neck squamous cell carcinoma
WO2023213623A1 (en) Dynamic sampling strategy for multiple-instance learning
EP4515457B1 (en) Multiple-instance learning based on regional embeddings
Dia et al. Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients
Dawood et al. Buyer Beware: confounding factors and biases abound when predicting omics-based biomarkers from histological images
CN118215970A (zh) 针对使用数字组织病理学图像预测癌症基因型和治疗反应的机器学习
Du et al. Optimal transport method-based gene filter (GF) denoising algorithm for enhancing spatially resolved transcriptomics data
Pan et al. A Deep Learning Framework Integrating Tumor Microenvironmental Features Accurately Predicts Multiple Driver Gene Mutations in Lung Cancer Pathology Images
Li et al. Research on predicting the progression of multiple myeloma treated with bortezomib based on multimodal ensemble learning
Komura et al. Deep texture representations as a universal encoder for pan-cancer histology
WO2023194090A1 (en) Multiple instance learning considering neighborhood aggregations
JP2025081279A (ja) 分子データを使用してｈｅｒ２状態を判定するための方法及びシステム
Wang et al. A variational sparse Gaussian-process method for detecting spatially variable genes and cellular interactions from spatial transcriptomics
Beltramey et al. HR-SCdan academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib
Lu et al. A deep learning approach for tissue spatial quantification and genomic correlations of histopathological images
Bairavi et al. An Ensemble AI Model for RET Alteration Detection Using H&E Images as a Putative Screening Tool for More Efficient Genomic Alteration Detection
Liu et al. Tissue Classification and Whole-Slide Images Analysis via Modeling of the Tumor Microenvironment and Biological Pathways

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240401

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240625

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240704

R150 Certificate of patent or registration of utility model

Ref document number: 7518097

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150